CAS No. 647032-00-6

L-Argininamide,L-tyrosyl-L-leucyl-L-arginyl-L-glutaminyl-L-seryl-L-glutaminyl-L-phenylalanyl-L-valylglycyl-L-seryl-

Catalog No.: 1063988
Name: L-Argininamide,L-tyrosyl-L-leucyl-L-arginyl-L-glutaminyl-L-seryl-L-glutaminyl-L-phenylalanyl-L-valylglycyl-L-seryl-
CAS: 647032-00-6
Formula: C59H94N20O16

Inquire about this product → | Safety data

Mrs.Camila Tel: +86 25 5874 5998 WhatsApp: +86 18136843696 Email to: sale@chemlab613.com

About L-Argininamide,L-tyrosyl-L-leucyl-L-arginyl-L-glutaminyl-L-seryl-L-glutaminyl-L-phenylalanyl-L-valylglycyl-L-seryl-

L-Argininamide,L-tyrosyl-L-leucyl-L-arginyl-L-glutaminyl-L-seryl-L-glutaminyl-L-phenylalanyl-L-valylglycyl-L-seryl- is a chemical compound registered under CAS number 647032-00-6, with the molecular formula C59H94N20O16 and a molecular weight of about 1339.52 g/mol. CasNo supplies L-Argininamide,L-tyrosyl-L-leucyl-L-arginyl-L-glutaminyl-L-seryl-L-glutaminyl-L-phenylalanyl-L-valylglycyl-L-seryl- for laboratory research and bulk production; product code 1063988. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 647032-00-6
Molecular Formula: C59H94N20O16
Molecular Weight: 1339.52 g/mol

Related Keywords

seryl

leucyl

tyrosyl

arginyl

glutaminyl

valylglycyl

argininamide

phenylalanyl

1,3-Dioxindiium

PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN)

Butanoic acid, 2-[bis[(phenylmethyl)thio]methylene]-3-oxo-

4-(4-{2-[(1-methyl-2-phenylethyl)amino]ethyl}phenoxy)phenol hydrochloride

ethanesulfonic acid- 4-{6-[4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2h)-yl)phenyl]hexyl}benzenesulfonyl fluoride(1:1)

GW 590735

622402-22-6

1H-Imidazo[2,1-d][1,2,5]dithiazepine-2-methanol,hexahydro-6,6,9,9-tetramethyl-

4-Quinolinecarboxylic acid,2-[10-[2-(dimethylamino)ethyl]-10H-phenothiazin-2-yl]-6-fluoro-,potassium salt

1H-2-Benzazepin-1-one, 2,3,4,5-tetrahydro-6-(phenylethynyl)-

1H-Benzimidazol-2-amine,1-[4-[(3,4-dimethoxyphenyl)amino]-1,3,5-triazin-2-yl]-

5-(4-chlorophenyl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

1H-Imidazole-5-carboxamide,1-[[5-(5-chloro-2-thienyl)-3-isoxazolyl]methyl]-4-methyl-N-[1-(1-methylethyl)-4-piperidinyl]-

701292-61-7

STYRYL METHYL ETHYL CARBINOL

Magnesium, bromo(5'-methyl[2,2'-bithiophen]-5-yl)-

Oxazolo[5,4-b]pyridine, 7-(4-chlorophenyl)-2,5-diphenyl-

5H-Cyclopenta[c]pyridine,1-(chloromethyl)-6,7-dihydro-4-(2-naphthalenyl)-

Phthalazine,1-[2-(dicyclohexylphosphino)-1-naphthalenyl]-4-[(1R)-1-phenylethoxy]-

ethanesulfonic acid- 5-chloro-2-{4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2h)-yl)phenyl]butyl}benzenesulfonyl fluoride(1:1)

31368-54-4

Hexane, 1,2,6-triisocyanato-

[1,1'-Biphenyl]-2-carboxamide,N-[(1S)-7-oxo-1-[[[2-(2-phenyl-1H-indol-3-yl)ethyl]amino]carbonyl]octyl]-

Benzoic acid, 2-(3-aminopropyl)-3-(phenylethynyl)-, methyl ester

3-(bromomethyl)-5-methoxyBenzenemethanol

(1aR,1bS,4aR,7aS,7bS,8R)-9-(acetyloxy)-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl tetradecanoate

1H-Benzimidazol-2-amine, 5-methyl-N-4-piperidinyl-, dihydrobromide

75970-50-2

pentatriacontane-10,12-diol

Thieno[2,3-d]pyrimidine-6-carbonitrile,2-(1,3-benzodioxol-5-yl)-4-[(2-hydroxyethyl)methylamino]-5-methyl-

Acetamide,N-[4-[[4'-[(1E)-2-[4-(2,4-dichlorophenyl)-1-ethyl-1H-imidazol-2-yl]ethenyl][1,1'-biphenyl]-4-yl]oxy]phenyl]-

2-(morpholin-4-ylmethyl)-10,11-dihydro-5H-dibenzo[b,f]azepine

(5e)-2-amino-5-(2,4-dimethoxybenzylidene)-1,3-thiazol-4(5h)-one

1H-Benzimidazole, 2-[(trimethylsilyl)oxy]-

873332-72-0

Itraconazole for system suitability

1,2,4-Triazolo[4,3-b][1,2,4]triazine,3-[(4-fluorophenyl)methyl]-7-(2-thienyl)-

2-allyl-2-(hydroxymethyl)propane-1,3-diol

3-Quinolinecarbonitrile, 4-chloro-7-(2-methoxyethoxy)-

3-Quinolinecarbonitrile, 7-fluoro-4-hydroxy-6-(phenylmethoxy)-

4,6-dihydro-Cyclopenta[b]pyrrol-5(1H)-one